ストックスクリーナーアプリを入手
39.21
4.69%
-1.93
前日終値:
$41.14
開ける：
$41.46
24時間の取引高:
304.23K
Relative Volume:
1.00
時価総額：
$1.75B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-10.27%
1か月 パフォーマンス:
+0.51%
6か月 パフォーマンス:
+87.88%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$38.93
$41.56
1週間の範囲:
$38.93
$45.00
52週間の値動き範囲:
$7.255
$45.00
Sionna Therapeutics Inc Stock (SION) Company Profile
名前
Sionna Therapeutics Inc
セクター
電話
617-819-2020
住所
21 HICKORY DRIVE, SUITE 500, WALTHAM
SION を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
39.21 | 1.84B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-01 | ダウングレード | RBC Capital Mkts | Sector Perform → Underperform |
| 2025-11-19 | 開始されました | BTIG Research | Buy |
| 2025-09-03 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-09-03 | 開始されました | Raymond James | Strong Buy |
| 2025-03-04 | 開始されました | Guggenheim | Buy |
| 2025-03-04 | 開始されました | Stifel | Buy |
| 2025-03-04 | 開始されました | TD Cowen | Buy |
すべてを表示
Sionna Therapeutics Inc (SION) 最新ニュース
Sionna Therapeutics Insider Sold Shares Worth $1,486,010, According to a Recent SEC Filing - marketscreener.com
Sionna Therapeutics (NASDAQ:SION) Director Peter Thompson Sells 33,356 Shares - Defense World
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 33,356 Shares of Stock - MarketBeat
OrbiMed Advisors sells Sionna Therapeutics [SION] shares for $1.48m By Investing.com - Investing.com Nigeria
OrbiMed Advisors sells Sionna Therapeutics [SION] shares for $1.48m - Investing.com
Sionna Therapeutics (NASDAQ:SION) Sets New 12-Month HighWhat's Next? - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Broadens Clinical Research Scope - Kalkine Media
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis - TipRanks
FY2025 Earnings Estimate for SION Issued By Lifesci Capital - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Now Covered by Analysts at Lifesci Capital - Defense World
LifeSci Capital Initiates Coverage of Sionna Therapeutics (SION) with Outperform Recommendation - Nasdaq
Sionna Therapeutics (NASDAQ:SION) Coverage Initiated by Analysts at Lifesci Capital - MarketBeat
LifeSci Capital Initiates Coverage on Sionna Therapeutics With Outperform Rating, $60 Price Target - marketscreener.com
Sionna Therapeutics (NASDAQ:SION) Director Sells $40,050.00 in Stock - Defense World
Sionna Therapeutics, Inc.(NasdaqGM:SION) added to S&P Biotechnology Select Industry Index - marketscreener.com
Sionna Therapeutics, Inc.(NasdaqGM: SION) added to NASDAQ Biotechnology Index - marketscreener.com
Sionna Therapeutics (NASDAQ:SION) Reaches New 1-Year High – Still a Buy? - Defense World
Peter Thompson Sells 900 Shares of Sionna Therapeutics (NASDAQ:SION) Stock - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Director Sells $38,928.75 in Stock - MarketBeat
Shareholder OrbiMed Advisors LLC Sells 1,875 ($83.4K) Of Sionna Therapeutics Inc [SION] - TradingView — Track All Markets
Sionna Therapeutics (NASDAQ:SION) Sets New 1-Year HighHere's What Happened - MarketBeat
How Sionna Therapeutics Inc. stock reacts to oil pricesTrade Entry Summary & Short-Term Trading Alerts - Улправда
Sionna Therapeutics, Inc. Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Sionna Therapeutics, Inc. Rings the Closing Bell - Nasdaq
Braidwell LP Invests $18.77 Million in Sionna Therapeutics, Inc. $SION - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Upgraded at Wall Street Zen - MarketBeat
Sionna Therapeutics (SION) Stock Analysis Report | Financials & Insights - Benzinga
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Sionna Therapeutics chief legal officer sells $415,330 in stock By Investing.com - Investing.com Canada
Sionna Therapeutics chief legal officer sells $415,330 in stock - Investing.com India
Sionna Therapeutics Insider Sold Shares Worth $415,330, According to a Recent SEC Filing - marketscreener.com
Officer Fitzpatrick Sells 10,250 ($415.3K) Of Sionna Therapeutics Inc [SION] - TradingView — Track All Markets
Bosun Asset Management LLC Invests $295,000 in Sionna Therapeutics, Inc. $SION - Defense World
Officer Fitzpatrick Files To Sell 10,250 Of Sionna Therapeutics Inc [SION] - TradingView
Sionna Therapeutics, Inc. $SION Shares Acquired by Prudential Financial Inc. - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Shares Up 11.4%What's Next? - MarketBeat
Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says - marketscreener.com
Transcript : Sionna Therapeutics, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09 - marketscreener.com
Why Sionna Therapeutics Inc. stock remains resilient2025 Short Interest & Long-Term Growth Portfolio Plans - Newser
Will Sionna Therapeutics Inc. stock gain from government policies - Newser
Sionna Therapeutics, Inc. $SION Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Shares Gap DownHere's What Happened - MarketBeat
Views of Wall Street’s Leading Experts on Sionna Therapeutics Inc - Setenews
Royal Bank Of Canada Reiterates "Underperform" Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeat
Is Sionna Therapeutics Inc. stock affected by interest rate hikesGold Moves & Precise Entry and Exit Recommendations - Newser
Sionna Therapeutics Shares Lower After RBC Downgrade - marketscreener.com
Sionna Therapeutics stock tumbles after RBC downgrade By Investing.com - Investing.com Canada
SION Downgraded by RBC Capital: Today's Analyst Rating | SION St - GuruFocus
Sionna Therapeutics Inc (SION) 財務データ
Sionna Therapeutics Inc (SION) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Sionna Therapeutics Inc (SION) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Thompson Peter A. | Director |
Dec 24 '25 |
Sale |
44.55 |
33,356 |
1,486,010 |
3,561,655 |
| ORBIMED ADVISORS LLC | Director |
Dec 17 '25 |
Sale |
44.50 |
900 |
40,050 |
3,595,986 |
| ORBIMED ADVISORS LLC | Director |
Dec 19 '25 |
Sale |
44.49 |
875 |
38,929 |
3,595,011 |
| ORBIMED ADVISORS LLC | Director |
Dec 18 '25 |
Sale |
44.49 |
100 |
4,449 |
3,595,886 |
| Thompson Peter A. | Director |
Dec 17 '25 |
Sale |
44.50 |
900 |
40,050 |
3,595,986 |
| Thompson Peter A. | Director |
Dec 19 '25 |
Sale |
44.49 |
875 |
38,929 |
3,595,011 |
| Thompson Peter A. | Director |
Dec 18 '25 |
Sale |
44.49 |
100 |
4,449 |
3,595,886 |
| Fitzpatrick Jennifer | Chief Legal Officer |
Dec 05 '25 |
Option Exercise |
6.11 |
10,250 |
62,628 |
10,250 |
| Fitzpatrick Jennifer | Chief Legal Officer |
Dec 05 '25 |
Sale |
40.52 |
10,250 |
415,330 |
0 |
0.57%
大文字化:
|
ボリューム (24 時間):